SoVote

Decentralized Democracy

Senate Bill

Bill S-260

44th Parl. 1st Sess.
June 13, 2023
National Diffuse Midline Glioma Awareness Day Act
  • Bill S-260 designates May 17th of every year as "National Diffuse Midline Glioma Awareness Day" in Canada. Diffuse midline glioma is a type of aggressive brain tumor that affects children and has no cure. The goal of this bill is to increase public awareness of the disease and encourage investment in research to improve prognosis and treatment. May 17th is already recognized as a diffuse midline glioma awareness day in other countries. This bill aims to honor those who have died from the disease and bring attention to the need for continued research and support.
  • H1
  • H2
  • H3
  • S1
  • S2
  • S3
  • RA
  • Yea
  • Nay
  • star_border

SteelmanSpren in Favour

  • The enactment of a National Diffuse Midline Glioma Awareness Day is a necessary step towards addressing the lack of public awareness surrounding this devastating and fatal disease that disproportionately affects young children. By designating the 17th day of May as such, it provides an opportunity to honour those who have died while ensuring that the urgency of finding a cure and improving treatments for those affected becomes more prominent. By increasing public and private investment in research, there is hope that the prognosis for those diagnosed with diffuse midline glioma will improve. Additionally, the recognition of this day in other countries highlights its global significance and reinforces Canada's commitment to tackling this issue. Overall, this legislation is an important step in raising awareness and encouraging progress towards finding a cure for diffuse midline glioma.

SteelmanSpren Against

  • One possible steelman argument opposing this bill could be that designating a specific day as "National Diffuse Midline Glioma Awareness Day" is not an effective solution to address the issue of this aggressive brain tumor. While raising awareness can be important, it may not lead to tangible improvements in research or treatments. Moreover, choosing a specific day may make it seem like the issue only needs attention on that day, instead of consistently working towards finding a cure or better treatments year-round. Additionally, the bill's focus on honoring those who have died from the disease may not be a productive use of resources in combatting the disease. Rather than designating a day for awareness, the government should focus on providing funding for research and treatments to improve the prognosis for those affected by diffuse midline glioma.
Senate Second Reading
  • April 20, 2023, 2 p.m.
  • In Progress
  • Read
Senate First Reading
  • April 20, 2023, 2 p.m.
  • Passed